Mary Redman

Mary Redman, PhD

S2302 Pragmatica-Lung biostatistician; Statistical chair, SWOG Lung Committee; Professor, Fred Hutchinson Cancer Center

Latest Stories
FreeGuest Editorial
S2302 Pragmatica-Lung is a federally-funded, streamlined clinical trial examining a new combination of agents in patients with advanced non-small cell lung cancer (NSCLC). Like most studies, it is focused on improving outcomes for patients with cancer—but it is also poised to simplify and transform the entire clinical trials model as we know it. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login